Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Company research

Kazia Therapeutics Limited/ADR

CIK 1055886Updated Sep 29, 2026

Name history
NOVOGEN LTD /ADR/ · through Nov 17, 2017

No exchange listing on record for this SEC filer. Coverage is drawn from its filings.

Filing activity

SEC EDGAR
Latest filing

EFFECT · Sep 25, 2026

10 filings on record · EFFECT, F-6, 424B3, F-6 POS.

Recent filings

  1. EFFECT filing

    EFFECT · 2026-09-25 · 9999999995-26-003070

  2. F-6 filing

    F-6 · 2026-09-18 · 0001193805-26-001248

  3. 424B3 filing

    424B3 · 2025-04-04 · 0001019155-25-000115

  4. 424B3 filing

    424B3 · 2024-10-16 · 0001019155-24-000301

  5. 424B3 filing

    424B3 · 2024-10-16 · 0001019155-24-000296

Show 5 more recent filings

  1. 424B3 filing

    424B3 · 2024-10-16 · 0001019155-24-000299

  2. 424B3 filing

    424B3 · 2017-11-21 · 0001019155-17-000278

  3. 424B3 filing

    424B3 · 2017-11-17 · 0001019155-17-000272

  4. 424B3 filing

    424B3 · 2017-07-11 · 0001019155-17-000204

  5. F-6 POS filing

    F-6 POS · 2016-06-06 · 0001019155-16-000599